Skip to Content

Teladar Side Effects

Generic Name: betamethasone topical

Note: This document contains side effect information about betamethasone topical. Some of the dosage forms listed on this page may not apply to the brand name Teladar.

For the Consumer

Applies to betamethasone topical: topical application cream, topical application lotion, topical application ointment, topical application spray

Other dosage forms:

Along with its needed effects, betamethasone topical (the active ingredient contained in Teladar) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking betamethasone topical:

More Common

  • Burning or stinging
  • itching at the application site

Less Common

  • Blistering, burning, crusting, dryness, or flaking of the skin
  • cracking or tightening of the skin
  • dry skin
  • flushing or redness of the skin
  • irritation
  • itching, scaling, severe redness, soreness, or swelling of the skin
  • thinning of the skin with easy bruising, especially when used on the face or where the skin folds together (eg, between the fingers)
  • unusually warm skin

Rare

  • Blistering, peeling, or loosening of the skin

Incidence Not Known

  • Blindness
  • blurred vision
  • change in vision
  • decreased vision
  • eye pain
  • headache
  • loss of vision
  • nausea
  • redness and scaling around the mouth
  • tearing
  • vomiting

Some side effects of betamethasone topical may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Less Common

  • Raised, dark red, or wart-like spots on the skin, especially when used on the face

Rare

  • Burning, itching, and pain in hairy areas, or pus at the root of the hair

Incidence Not Known

  • Acne or pimples
  • burning and itching of the skin with pinhead-sized red blisters
  • increased hair growth on the forehead, back, arms, and legs
  • lightening of normal skin color
  • lightening of treated areas of dark skin
  • reddish purple lines on the arms, face, legs, trunk, or groin
  • softening of the skin

For Healthcare Professionals

Applies to betamethasone topical: topical cream, topical foam, topical gel, topical lotion, topical ointment, topical spray

General

The most commonly reported side effects were pruritus, burning, itching, irritation.

Hypersensitivity

Rare (less than 0.1%): Hypersensitivity

Endocrine

Frequency not reported: Cushing's syndrome[Ref]

Dermatologic

Common (1% to 10%): Pruritus

Uncommon (0.1% to 1%): Folliculitis, skin infections (including bacterial, fungal and viral skin infections)

Frequency not reported: Dryness, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infections, skin atrophy, striae, miliaria[Ref]

Local

Uncommon (0.1% to 1%): Application site pain

Frequency not reported: Burning, itching, irritation[Ref]

Ocular

Rare (less than 0.1%): Eye disorder

Postmarketing reports: cataracts, glaucoma, increased intraocular pressure, central serous chorioretinopathy[Ref]

Metabolic

Frequency not reported: Hyperglycemia

Renal

Frequency not reported: Glucosuria

Other

Rare (less than 0.1%): Rebound effect

References

1. Ruiz-Maldonado R, Zapata G, Lourdes T, Robles C "Cushing's syndrome after topical application of corticosteroids." Am J Dis Child 136 (1982): 274-5

2. "Product Information. Diprolene (betamethasone topical)." Schering Laboratories, Kenilworth, NJ.

3. Flynn MD, Beasley P, Tooke JE "Adrenal suppression with intranasal betamethasone drops." J Laryngol Otol 106 (1992): 827-8

4. Stevens DJ "Cushing's syndrome due to the abuse of betamethasone nasal drops." J Laryngol Otol 102 (1988): 219-21

5. Walsh P, Aeling JL, Huff L, Weston WL "Hypothalamus-pituitary-adrenal axis suppression by superpotent topical steroids." J Am Acad Dermatol 29 (1993): 501-3

6. Salde L, Lassus A "Systemic side-effects of three topical steroids in diseased skin." Curr Med Res Opin 8 (1983): 475-80

7. Stoppoloni G, Prisco F, Santinelli R, Sicuranza G, Giordano C "Potential hazards of topical steroid therapy." Am J Dis Child 137 (1983): 1130-1

8. Reymann F, Kehlet H "Hypothalamic-pituitary-adrenocortical function. Association with topical application of betamethasone dipropionate." Arch Dermatol 115 (1979): 362-3

9. Cunliffe WJ, Burton JL, Holti G, Wright V "Hazards of steroid therapy in hepatic failure." Br J Dermatol 93 (1975): 183-5

10. Macdonald A "Topical corticosteroid preparations. Hazards and side-effects." Br J Clin Pract 25 (1971): 421-5

11. Smith EB, Breneman DL, Griffith RF, Hebert AA, Hickman JG, Maloney JM, Millikan LE, Sulica VI, Dromgoole SH, Sefton J, et al "Double-blind comparison of naftifine cream and clotrimazole/betamethasone dipropionate cream in the treatment of tinea pedis." J Am Acad Dermatol 26 (1992): 125-7

12. Hellgren L "Induction of generalized pustular psoriasis by topical use of betamethasone-dipropionate ointment in psoriasis." Ann Clin Res 8 (1976): 317-9

13. Grice K "Tinea of the hand and forearm. Betamethasone valerate atrophy." Proc R Soc Med 59 (1966): 254-5

14. Sneddon I "Perioral dermatitis." Br J Dermatol 87 (1972): 430-4

15. Barkey WF "Striae and persistent tinea corporis related to prolonged use of betamethasone dipropionate 0.05% cream/clotrimazole 1% cream (Lotrisone cream)." J Am Acad Dermatol 17 (1987): 518-9

16. Ellis CN, Katz HI, Rex IH Jr, Shavin JS, Van Scott EJ, VanderPloeg D "A controlled clinical trial of a new formulation of betamethasone dipropionate cream in once-daily treatment of psoriasis." Clin Ther 11 (1989): 768-74

17. Butcher JM, Austin M, McGalliard J, Bourke RD "Bilateral cataracts and glaucoma induced by long term use of steroid eye drops." BMJ 309 (1994): 43

18. Eisenlohr JE "Glaucoma following the prolonged use of topical steroid medication to the eyelids." J Am Acad Dermatol 8 (1983): 878-81

19. Kitazawa Y "Increased intraocular pressure induced by corticosteroids." Am J Ophthalmol 82 (1976): 492-5

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.

Hide